Blood test uses artificial intelligence and biomarkers to prenatally detect fetal congenital heart defects

Researchers at Beaumont Hospital, Royal Oak, have discovered a blood test for pregnant women that uses artificial intelligence and genetic-related biomarkers to accurately detect, fetal congenital heart defects, well before birth.
Researchers at Beaumont Hospital, Royal Oak, have discovered a blood test for pregnant women that uses artificial intelligence and genetic-related biomarkers to accurately detect, fetal congenital heart defects, well before birth.